LIR Life Sciences Corp. BBCMF
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -708.50K | -1.02M | -1.56M | -141.20K | -102.00K |
| Total Depreciation and Amortization | -- | 900.00 | 1.00K | 1.00K | 800.00 |
| Total Amortization of Deferred Charges | -- | -239.00K | 236.30K | -- | -- |
| Total Other Non-Cash Items | 288.60K | 977.50K | 489.10K | -100.00 | 100.00 |
| Change in Net Operating Assets | 136.60K | -24.20K | -298.80K | 136.40K | 66.00K |
| Cash from Operations | -283.20K | -305.00K | -1.13M | -4.00K | -35.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 71.10K | 1.03M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 0.00 | -76.40K |
| Cash from Investing | -- | 71.10K | 1.03M | 0.00 | -76.40K |
| Total Debt Issued | -- | 0.00 | 0.00 | 5.00K | 35.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 1.07M | -- |
| Repurchase of Common Stock | -- | 0.00 | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -3.40K | -- | -- | -- |
| Cash from Financing | -- | -2.50K | 0.00 | 773.00K | 25.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -283.20K | -236.40K | -107.40K | 768.90K | -86.10K |